Updated daily
Drug recalls
Every FDA drug recall since 2004 - 18,109 enforcement reports, newest first, with what was recalled, why, the lots and the company. Class I is the most serious.
Class IITerminatedJul 31, 2013Diclofenac Sodium and Misoprostol Delayed-Release TabletsFailed Tablet/Capsule Specifications: Broken tabletsWatson Laboratories, Inc.-(Actavis) - Florida · D-817-2013Class IIITerminatedJul 31, 2013LA MER the spf 18 fluid tintSubpotent drug: Avobenzone 3%, one of the active sunscreen ingredients may be subpotent and sunscreen effectiveness may be less than labeledMax Huber Research Labs, Inc. · D-816-2013Class IIITerminatedJul 31, 2013LA MER the spf 18 fluid tintSubpotent Drug: Avobenzone 3%, one of the active sunscreen ingredients may be subpotent and sunscreen effectiveness may be less than labeledMax Huber Research Labs, Inc. · D-815-2013Class IIITerminatedJul 31, 2013LA MER the spf 18 fluid tintSubpotent Drug: Avobenzone 3%, one of the active sunscreen ingredients may be subpotent and sunscreen effectiveness may be less than labeledMax Huber Research Labs, Inc. · D-814-2013Class IITerminatedJul 31, 2013Sodium Chloride InjectionPresence of Particulate Matter: Confirmed customer report of visible particulate in the form of an orange or rust colored ring embedded in between the plastic layers of...Hospira Inc. · D-813-2013Class IIITerminatedJul 31, 2013ALCOHOL FREE ANTISEPTICMicrobial Contamination of Non-Sterile Products: This product is being recalled because a stability sample was found to be contaminated with Burkholderia contaminans.Vi-Jon, Inc. · D-812-2013Class IITerminatedJul 31, 2013All Compounded ProductsLack of Assurance of Sterility; potential for mold contaminationMed Prep Consulting, Inc. · D-811-2013Class ITerminatedJul 31, 2013Magnesium Sulfate 2 grams in Dextrose 5% for InjectionNon-Sterility; mold contaminationMed Prep Consulting, Inc. · D-810-2013Class ITerminatedJul 31, 2013MitosolNon-Sterility: one or more components of the kit have been found to be contaminated with yeast.Mobius Therapeutics LLC · D-809-2013Class IIITerminatedJul 31, 2013Pharmalucence Kit for the Preparation of Technetium Tc 99m Sestamibi Injection for Mycardial and Breast...Presence of Particulate Matter; particulate found in retain samplesPharmalucence, Inc. · D-808-2013Class IIITerminatedJul 24, 2013Medroxyprogesterone acetateFailed Stability Specifications: Out of specification results for particle size were obtained at the 60 month test point.Bayer HealthCare Pharmaceuticals Inc. · D-807-2013Class ITerminatedJul 24, 2013Piperacillin and Tazobactam for InjectionCrystallization: Potential to exhibit precipitation/crystallization in IV bag or IV line upon reconstitution.Apotex Corp. · D-806-2013Class IITerminatedJul 24, 2013EstaryllaContraceptive Tablets out of Sequence: A placebo tablet was found in a row of active tablets.Sandoz Incorporated · D-805-2013Class IITerminatedJul 24, 2013Oxytocin InjectionSubpotent Drug; 15-month stability test stationFresenius Kabi USA, LLC · D-804-2013Class IIITerminatedJul 24, 2013Amoxicillin for Oral SuspensionDiscoloration: This recall is being carried out due to an orange to brown discolored Amoxicillin powder on the inner foil seal of the bottles. This is an expansion of...Teva Pharmaceuticals USA, Inc. · D-803-2013Class IITerminatedJul 24, 2013QUETIAPINE Fumarate Tablets 25mg 100 TabletsFailed Dissolution Test Requirements: During analysis of long term stability studies at 3 months time point, an OOS was reported for Quetiapine Fumarate Tablets, 25 mg.American Health Packaging · D-802-2013Class IITerminatedJul 24, 2013Sodium Bicarbonate PowderPresence of Foreign Substance: raw material recalled due to stainless steel and other contamination.Church & Dwight Inc · D-801-2013Class IITerminatedJul 24, 2013Sodium Bicarbonate PowderPresence of Foreign Substance: raw material recalled due to stainless steel and other contamination.Church & Dwight Inc · D-800-2013Class IITerminatedJul 24, 2013Sodium Bicarbonate PowderPresence of Foreign Substance: raw material recalled due to stainless steel and other contamination.Church & Dwight Inc · D-799-2013Class IITerminatedJul 24, 2013Sodium Bicarbonate PowderPresence of Foreign Substance: raw material recalled due to stainless steel and other contamination.Church & Dwight Inc · D-798-2013Class IITerminatedJul 24, 2013Sodium Bicarbonate PowderPresence of Foreign Substance: raw material recalled due to stainless steel and other contamination.Church & Dwight Inc · D-797-2013Class IIOngoingJul 17, 2013Yohimbine 10 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-796-2013Class IIOngoingJul 17, 2013Xylazine 300 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-795-2013Class IIOngoingJul 17, 2013Voriconazole 5% Ophthalmic drop compounded by Olympia PharmacyLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-794-2013Class IIOngoingJul 17, 2013Vitamin B-Buildup InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-793-2013Class IIOngoingJul 17, 2013Vitamin B12 Cyanocobalamin 5000 mcg InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-792-2013Class IIOngoingJul 17, 2013Vitamin B12Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-791-2013Class IIOngoingJul 17, 2013Vitamin A/D3/E Olive Oil InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-790-2013Class IIOngoingJul 17, 2013Vitamin 15Lack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-789-2013Class IIOngoingJul 17, 2013Tripelennamine 20 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-788-2013Class IIOngoingJul 17, 2013Trimix, compounded by Olympia PharmacyLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-787-2013Class IIOngoingJul 17, 2013Testosterone CypionateLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-786-2013Class IIOngoingJul 17, 2013Taurine 100 mg/ml InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-785-2013Class IIOngoingJul 17, 2013TacrolimusLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-784-2013Class IIOngoingJul 17, 2013StanozololLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-783-2013Class IIOngoingJul 17, 2013Sodium Tetradecyl SulfateLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-782-2013Class IIOngoingJul 17, 2013Sodium Salicylate 40% InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-781-2013Class IIOngoingJul 17, 2013Sodium Iodide 20% InjectionLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-780-2013Class IIOngoingJul 17, 2013Sermorelin/GHRP 3 mg/3 mg vialLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-779-2013Class IIOngoingJul 17, 2013Quadmix, compounded by Olympia PharmacyLack of Assurance of Sterility: FDA inspection findings resulted in concerns regarding quality control processesLowlite Investments, Inc. D/B/A Olympia Pharmacy · D-778-2013